Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
21.27
+0.29 (1.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Definium Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -183.79 | -108.68 | -95.73 | -56.8 | -93.04 | |
| Depreciation & Amortization | - | - | -0.04 | -0.02 | 0.02 | |
| Other Amortization | - | 0.53 | 3.3 | 4.7 | 2.6 | |
| Loss (Gain) From Sale of Investments | -1.82 | - | - | - | - | |
| Stock-Based Compensation | 21.56 | 17.67 | 15.49 | 13.71 | 42.72 | |
| Other Operating Activities | 23.06 | 14.69 | 6.33 | -7.95 | - | |
| Change in Accounts Payable | 3.34 | -2.13 | 2.03 | -2.06 | 1.28 | |
| Change in Other Net Operating Assets | 6.1 | -1.22 | 4.26 | -1.73 | 1.76 | |
| Operating Cash Flow | -131.56 | -79.13 | -64.37 | -50.14 | -45.82 | |
| Cash Acquisitions | - | - | - | - | -0.3 | |
| Investment in Securities | -151.61 | - | - | - | - | |
| Investing Cash Flow | -151.61 | - | - | - | -0.3 | |
| Long-Term Debt Issued | 42 | 10 | 15 | - | - | |
| Long-Term Debt Repaid | -22 | - | - | - | - | |
| Net Debt Issued (Repaid) | 20 | 10 | 15 | - | - | |
| Issuance of Common Stock | 263.66 | 259.97 | 7.69 | 43.21 | 98.82 | |
| Repurchase of Common Stock | - | -0.05 | - | -0.41 | - | |
| Other Financing Activities | -16.39 | -16.72 | -0.84 | 16.25 | - | |
| Financing Cash Flow | 267.27 | 253.2 | 21.85 | 59.05 | 98.82 | |
| Foreign Exchange Rate Adjustments | -0.01 | -0.03 | 0.08 | -0.31 | 0.74 | |
| Net Cash Flow | -15.9 | 174.04 | -42.44 | 8.6 | 53.45 | |
| Cash Interest Paid | 5.34 | 2.22 | 0.53 | - | - | |
| Levered Free Cash Flow | -57.81 | -45.28 | -26.39 | -15.82 | -8.21 | |
| Unlevered Free Cash Flow | -54.39 | -43.85 | -25.91 | -15.82 | -7.99 | |
| Change in Working Capital | 9.44 | -3.34 | 6.28 | -3.78 | 1.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.